Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA

 (UNC)
0
Real-time Quote. Real-time Tradegate - 05/17 03:59:46 pm
44.555 EUR   -1.48%
2d ago UCB: and IBM Collaborate to Personalize Care for Epilepsy Patients
05/09 UCB: Acquisition of own shares (09 05)
05/02 UCB: ex-dividend day for annual dividend
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse AG
05/13/2013 05/14/2013 05/15/2013 05/16/2013 05/17/2013 Date
45.64(c) 45.277(c) 45.294(c) 45.225(c) 44.357(c) Last
43 0 0 34 17 Volume
-0.22% -0.80% +0.04% -0.15% -1.92% Change
More quotes
Company
UCB is a biopharmaceutical company focused on the discovery and the development of innovative medicines in the fields of central nervous system and immunology disorders. Net sales break down by activity as follows: - sales of bio-pharmaceutical products (88.7%): for treating central nervous system... 
Read more
Surperformance© rating of UCB SA
Trading Rating : Investor Rating :
More about the company
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2013 3 446 M
EBIT 2013 501 M
Net income 2013 254 M
Debt 2013 1 701 M
Yield 2013 2,33%
Sales 2014 3 645 M
EBIT 2014 612 M
Net income 2014 330 M
Debt 2014 1 450 M
Yield 2014 2,48%
PER 2013 30,89
PER 2014 22,98
EV / Sales 2013 2,87x
EV / Sales 2014 2,64x
Capitalization 8 179 M
More Financials
Latest news on UCB SA
2d ago UCB: and IBM Collaborate to Personalize Care for Epilepsy Patients
05/09 UCB: Acquisition of own shares (09 05)
05/02 UCB: ex-dividend day for annual dividend
04/25 UCB: UCB's shareholder meeting today
04/25 UCB: Slow Start but Outlook 2013 and Growth Prospects Confirmed
04/22UCB SA: quaterly earnings release
03/28 UCB: Acquisition of own shares
03/26 UCB: SA/NV - Convocation to the Annual General Shareholders' meeting
03/19 UCB: New data Released on Switching Parkinson's Disease Patients with Pre-Exist..
03/19 UCB: and Five Prime Therapeutics announce strategic discovery collaboration
03/14 UCB: Acquisition of own shares
03/11 UCB: Acquisition of own shares
More news
Forum UCB SA
Be the first to post a message on UCB SA
Advertisement
Income Statement Evolution
UCB SA : Income Statement Evolution
More Financials
EPS Revisions
UCB SA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.